Interferon γ impairs the ability of monocyte-derived dendritic cells to present tumour-specific and allo-specific antigens and reduces their expression of CD1a, CD80 and CD4

Cytokine

Volumn 10, Issue 10, 1998, Pages 747-755

  Rongcun, Yang ^a,c   Maes, Hubert ^a,c   Corsi, Massimiliano ^b   Dellner, Fredrik ^a,c   Wen, Tao ^a   Kiessling, Rolf ^a,c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF MILAN   (Italy)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Dendritic cell; IFN ; Monocyte

Indexed keywords

ALLOANTIBODY; B7 ANTIGEN; CD1 ANTIGEN; CD11 ANTIGEN; CD4 ANTIGEN; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HLA A ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 4; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TUMOR ANTIGEN;

ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; CULTURE MEDIUM; DENDRITIC CELL; FEEDBACK SYSTEM; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOREGULATION; MONONUCLEAR CELL; PRIORITY JOURNAL;

EID: 0032192397     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.1998.0357     Document Type: Article

References (50)

1. 1. Becker Y (1992) Anticancer role of dendritic cells (DC) in human and experimental cancers - a review. Anticancer Res 12:511-520.
2. 2. Mayordomo JI, Zorina T, Storkus WJ, Zitvogel L, Celluzzi C, Falo LD, Melief CJ, Ildstad ST, Kast WM, Deleo AB, Lotze MT (1995) Bone marrow-derived dendritic cells pulsed with synthetic tumor peptides elicit protective and therapeutic antitumor immunity. Nature Med 1:1297-1302.
3. 3. Marland G, Bakker AB, Adema GJ, Figdor CG (1996) Dendritic cells in immune response induction. Stem Cells 14:501-507.
4. 4. Steinman RM (1991) The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 9:271-296.
5. 5. Caux C, Liu YJ, Banchereau J (1995) Recent advances in the study of dendritic cells and follicular dendritic cells. Immunol Today 16:2-4.
6. 6. Young JW, Steinman RM (1996) The hematopoietic development of dendritic cells: a distinct pathway for myeloid differentiation. Stem Cells 14:376-387.
7. 7. Jonuleit H, Knop J, Enk AH (1996) Cytokines and their effects on maturation, differentiation and migration of dendritic cells. Arch Dermatol Res 289:1-8.
8. 8. Ozawa H, Aiba S, Nakagawa S, Tagami H (1996) Interferon-γ and interleukin-10 inhibit antigen presentation by Langerhans cells to T helper type 1 cells by suppressing their CD80 (B7.1) expression. Eur J Immunol 26:648-652.
9. 9. Mitra RS, Judge TA, Nestle FO, Turka LA, Nickoloff BJ (1995) Psoriatic skin-derived dendritic cell function is inhibited by exogenous IL-10. Differential modulation of B7.1 (CD80) and B7.2 (CD86) expression. J Immunol 154:2668-2677.
10. + cytotoxic T cells. Immunol Res 15:126-140.
11. 11. Dubey C, Croft M (1996) Accessory molecule regulation of naive CD4 T cell activation. Immunol Res 15:114-125.
12. 12. Porcelli SA (1995) The CD1 family: a third lineage of antigen presenting molecules. Adv Immunol 59:1-98.
13. + hematopoietic progenitor cells. Blood 87:1292-1302.
14. 14. Chapuis F, Rosenzwajg M, Yagello M, Ekman M, Biberfeld P, Gluckman JC (1997) Differentiation of human dendritic cells from monocytes in vitro. Eur J Immunol 27:431-441.
15. 15. Fowlkes BJ, Edison L, Mathieson BJ, Chused TM (1985) Early T lymphocytes: differentiation in vivo of adult intrathymic precursor cells. J Exp Med 162:802-822.
16. 16. Haynes BF, Denning SM, Singer KH, Kurtzberg J (1989) Ontogeny of T-cell precursors: a model for the initial stages of T-cell development. Immunol Today 10:87-91.
17. 17. Romani N, Gruner S, Brang D, Kämpgen E, Lenz A, Trockenbacher B, Konwalinka G, Fritsch PO, Steinman RM, Schuler G (1994) Proliferating dendritic cell progenitors in human blood. J Exp Med 180:83-93.
18. 18. Kronin V, Winkel K, Süss G, Kelso A, Heath W, Kirberg J, von Boehmer H, Shortman K (1996) A subclass of dendritic cells regulate the response of naive CD8 T cells by limiting their IL-2 production. J Immunol 157:3819-3827.
19. + dendritic cells (DC) veto cells? The role of CD8 on DC development and in the regulation of CD4 and CD8 T cell responses. Int Immunol 9:1061-1064.
20. 20. Sotzik F, Rosenberg Y, Boyd AW, Honeyman M, Metcalf D, Scollay R, Wu L, Shortman K (1994) Assessment of CD4 expression by early T precursor cells and by dendritic cells in the human thymus. J Immunol 52:3370-3377.
21. 21. Inaba K, Inaba M, Romani N, Aya H, Deguchi M, Ikehara S, Muramatsu S, Steinman RM (1992) Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med 176:1693-1702.
22. 22. Jaffe R (1993) Review of human dendritic cells: isolation and culture from precursors. Pediatr Pathol 13:821-837.
23. 23. Caux C, Dezutter-Dambuyant C, Schmitt D, Banchereau J (1992) GM-CSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells. Nature 360:258-261.
24. + bone marrow progenitors that are expanded by c-kit-ligand and yield pure dendritic cell colonies in the presence of granulocyte/ macrophage colony-stimulating factor and tumor necrosis factor alpha. J Exp Med 182:1111-1120.
25. + bone marrow precursors cultured in c-kit-ligand, granulocyte/macrophage colony-stimulating factor and TNF-alpha. J Immunol 154: 5851-5861.
26. + hematopoietic progenitors from human cord blood differentiate along two identical dendritic cell pathways in response to GM-CSF + TNF-alpha. J Exp Med 184: 695-706.
27. 27. Sallusto F, Lanzacecchia A (1994) Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 179:1109-1118.
28. 28. Wasseman K, Corsi M, Szekely L, Kono K, Maes HH, Kiessling R (1996) Conversion of in vitro cultured human monocytes into effective presenters of an HER2/neu-encoded CTL peptide epitope. Scand J Immunol 45:678-682.
29. + leukocytes acquire the phenotype and function of antigen-presenting dendritic cells when cultured in GM-CSF and IL-4. J Leukoc Biol 59:208-218.
30. 30. Maraskovsky E, Brasel K, Teepe M, Roux ER, Lyman SD, Shrtman K, McKenna H (1996) Dramatic increase in the numbers of functionally mature dendritic cells in FLT3 ligand-treated mice: multiple dendritic cell subpopulations identified. J Exp Med 184:1953-1962.
31. 31. Farrar MA, Schreiber RD (1993) The molecular cell biology of interferon-gamma and its receptor. Annu Rev Immunol 11:571-611.
32. + dendritic cells and tartrate-resistant acid phosphatase positive osteoclast-like multinucleated giant cells from human monocytes. Blood 88:4029-4039.
33. + cells in the human thymus are defined by expression of CD34. Delineation of early events in human thymic development. J Exp Med 178:391-401.
34. 34. Chaux P, Hamman A, Martin F, Martin M (1993) Surface phenotype and functions of tumor-infiltrating dendritic cells: CD8 expression by a cell subpopulation. Eur J Immunol 23:2517-2525.
35. 35. Süss G, Shrotman K (1995) A subclass of dendritic cells kills CD4 T cells via Fas/Fas-ligand-induced apoptosis. J Exp Med 183:1789-1796.
36. 36. Bakker AB, Marland G, de Boer AJ, Huijbens RJ, Danen EH, Adema GJ, Figdor CG (1995) Generation of anti-melanoma cytotoxic T lymphocytes from healthy donors after presentation of melanoma-associated antigen-derived epitopes by dendritic cells in vitro. Cancer Res 55:5330-5334.
37. 37. Hokland M, Basse P, Justesen J, Hokland P (1988) IFN-induced modulation of histocompatibility antigens on human cells. Background mechanisms and perspectives. Cancer Metastasis Rev 7:193-207.
38. 38. Akbar SM, Inaba K, Onji M (1996) Upregulation of MHC class II antigen on dendritic cells from hepatitis B virus transgenic mice by interferon gamma: abrogation of immune response defect to a T-cell-dependent antigen. Immunology 87:519-527.
39. 39. Ramarathinam L, Castle M, Wu Y, Liu Y (1994) T cell costimulation by B7/BB1 induces CD8 T cell-dependent tumor rejection and important role of B7/BB1 in the induction, recruitment, and effector function of antitumor cells. J Exp Med 179:1205-1214.
40. + cells: role of CD28 costimulation. Scand J Immunol 44:21-29.
41. 41. Blumberg RS, Gerdes D, Chott A, Porcelli SA, Balk SP (1995) Structure and function of the CD1 family of MHC-like cell surface proteins. Immunol Rev 147:5-29.
42. 42. Melian A, Beckman EM, Porcelli SA, Brenner MB (1996) Antigen presentation by CD1 and MHC-encoded class I-like molecules. Curr Opin Immunol 8:82-88.
43. 43. Bendelac A, Hunziker RD, Lantz O (1996) Increased interleukin 4 and immunoglobulin E production in transgenic mice overexpressing NK1T cells. J Exp Med 184:1285-1293.
44. 44. Germain RM, Margulies DH (1993) The biochemistry and cell biology of antigen processing and presentation. Annu Rev Immunol 11:403-450.
45. 45. Kuchroo VK, Das MP, Brown JA, Ranger AM, Zamvil SS, Sobel RA, Weiner HL, Nabavi N, Glimcher LH (1995) B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 80:707-718.
46. 46. Pisa P, Halapi E, Pisa E, Hising C, Gerdin E, Bucht A, Gerdin B, Kiessling R (1992) Selective expression of interleukin 10, interferon γ and granulocyte-macrophage colony-stimulating factor in ovarian cancer biopsies. Proc Natl Acad Sci USA 89:7708-7712.
47. 47. Berchuck A, Kamel A, Whitaker R, Kerns B, Olt G, Kinney R, Soper JT, Dodge R, Clarke-Pearson DL, Marks P, Mckenzie P, Yin S, Bast JRC (1990) Overexpression of HER2/neu is associated with poor survival in advanced epithelial ovarian cancer. Cancer Res 50:4087-4091.
48. 48. Nakagomi H, Pisa P, Pisa E, Yamamoto Y, Halapi E, Backlin K, Juhlin C, Kiessling R (1995) Lack of interleukin-2 (IL-2) expression and selective expression of IL-10 mRNA in tumor infiltrating cells of human renal cell carcinoma. Int J Cancer 63:366-371.
49. 49. Qin Z, Noffz G, Mohaupt M, Blankenstein T (1997) Interleukine 10 prevents dendritic cell accumulation and vaccination with GM-CSF gene-modified tumor cells. J Immunol 159:770-776.
50. + T cell clones specific for the HER-2/neu proto-oncogene expressed on ovarian carcinomas: related and unrelated to decreased MHC class 1 expression. Int J Cancer 70:112-119.